Definium Therapeutics, Inc. Shareholders' Equity
Definium Therapeutics, Inc. (DFTX) had Shareholders' Equity of $918.68 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $918.68M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $278.85M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $332.33M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $130.60M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $918.68M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $278.85M 10-Q · filed 2026-08-06 |
| 2025-12-31 | $332.33M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $130.60M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $185.40M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $222.81M 10-Q · filed 2026-08-06 |
| 2024-12-31 | $241.45M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $262.19M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $202.05M 10-Q · filed 2025-11-06 |
| 2024-03-31 | $196.06M 10-Q · filed 2025-11-06 |
| 2023-12-31 | $78.13M 10-K · filed 2026-02-26 |
| 2023-09-30 | $95.98M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $105.97M 10-Q · filed 2024-11-07 |
| 2023-03-31 | $130.34M 10-Q · filed 2024-08-13 |
| 2022-12-31 | $150.92M 10-K · filed 2025-03-06 |
| 2022-09-30 | $153.59M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $124.50M 10-Q · filed 2023-11-02 |
| 2022-03-31 | $136.81M 10-Q · filed 2023-08-03 |
| 2021-12-31 | $151.66M 10-K · filed 2024-02-28 |
| 2021-09-30 | $164.27M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $171.63M 10-Q · filed 2022-11-10 |
| 2021-03-31 | $180.59M 10-Q · filed 2022-08-11 |
| 2020-12-31 | $75.87M 10-K · filed 2023-03-09 |
| 2019-12-31 | $4.78M 10-K · filed 2022-03-28 |
| 2019-05-29 | $0.00 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |